« PreviousNext »American Journal of Cardiology
Volume 97, Issue 8, Supplement 1 , Pages S77-S81, 17 April 2006
Volume 97, Issue 8, Supplement 1 , Pages S77-S81, 17 April 2006
An Assessment of Statin Safety by Hepatologists
The purpose of the Liver Expert Panel was to provide advice to the National Lipid Association’s (NLA) Safety Task Force in response to specific questions concerning liver-associated risks of statin therapy. The panel was composed of academic hepatologists with clinical and research interests in nonalcoholic fatty liver disease, lipid metabolic disorders, and drug hepatotoxicity.
To access this article, please choose from the options below
PII: S0002-9149(05)02147-8
doi:10.1016/j.amjcard.2005.12.014
© 2006 Elsevier Inc. All rights reserved.
« PreviousNext »American Journal of Cardiology
Volume 97, Issue 8, Supplement 1 , Pages S77-S81, 17 April 2006
Volume 97, Issue 8, Supplement 1 , Pages S77-S81, 17 April 2006
